Feedback / Questions
Equidacent (bevacizumab biosimilar) - Fujifilm Kyowa Kirin Biologics, AstraZeneca, Centus Biotherap
https://www.centerforbiosimilars.com/view/centus-bevacizumab-candidate-demonstrates-equivalence-in-phase-3-study
Aug 19, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next